Bridging the Divide: The Urgent Need for Open Dialogue in America’s Pharmaceutical Landscape
Affordable medications remain out of reach for many Americans due to the monopolistic practices of Big Pharma and stifled discussions about alternative solutions. Open dialogue about international pharmaceutical standards, especially from countries like India, is crucial. We must advocate for policy changes to foster transparency and inclusivity in healthcare discussions, ensuring cost-effective solutions are accessible to all.